Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Withdrawn1
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

withdrawn133%
completed133%
active_not_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

EASE: The Materna Prep Pivotal Study

NCT03973281
withdrawnnot_applicable

A Clinical Phase II Study of the Materna Device to Shorten Delivery Time During Childbirth

NCT06698185
completedphase_2

Materna Prep Study Phase II

NCT06126328

Clinical Trials (3)

Showing 3 of 3 trials
NCT03973281Not Applicable

EASE: The Materna Prep Pivotal Study

Active Not Recruiting
NCT06698185Not Applicable

A Clinical Phase II Study of the Materna Device to Shorten Delivery Time During Childbirth

Withdrawn
NCT06126328Phase 2

Materna Prep Study Phase II

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3